[{"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-001", "question": "A 43-year-old woman undergoes bilateral DIEP free flap breast reconstruction after nipple-sparing mastectomy. Intraoperatively, the right flap requires an 11-cm venous graft to reach the internal mammary vein, and flow is satisfactory at closure. On postoperative day 3, she develops progressive swelling and violaceous discoloration of the right flap with brisk bleeding on pinprick and Dopplerable arterial signal in the pedicle but no venous signal. Exploration shows a patent arterial anastomosis, a soft flap, and a congested, thrombotic venous graft with limited nearby recipient veins. The contralateral internal mammary and thoracodorsal systems are already occupied by the left flap. Which salvage strategy offers the highest likelihood of durable flap survival?", "options": ["Shortening the flap pedicle with reanastomosis directly to the internal mammary vein after partial flap debulking to reduce reach and venous load", "Use of a retrograde internal mammary vein anastomosis via a newly dissected contralateral internal mammary perforator and interposition venous graft", "Creation of a venous cross-over (cross-chest) anastomosis from the congested flap vein to a contralateral DIEP flap superficial inferior epigastric vein branch", "Conversion of the free flap to a pedicled bipedicled transverse rectus abdominis myocutaneous (TRAM) flap by re-establishing inferior epigastric inflow and rotating the flap on its native pedicle", "Immediate complete flap removal and delayed reconstruction with a latissimus dorsi flap and implant after chemotherapy and radiation are completed"], "answer": "C", "answer_index": 2, "explanation": "Venous cross-over using a contralateral flap vein (often SIEV) is a recognized, high-yield salvage when ipsilateral recipient veins are exhausted, preserving a viable free flap. Shortening the pedicle (A) is not feasible given the reach problem and does not address lack of recipient vein; retrograde IMV with another vein graft (B) adds another long, failure-prone segment. Converting to pedicled TRAM (D) is not realistic once the flap is fully disconnected. Immediate flap loss (E) is last resort and avoids a proven microvascular salvage option.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: free flap with venous graft, postoperative venous congestion (swelling, violaceous discoloration, brisk bleeding on pinprick, no venous signal), patent arterial anastomosis, thrombotic venous graft, limited nearby recipient veins, contralateral internal mammary and thoracodorsal systems already occupied. The scenario uniquely points to venous outflow salvage when ipsilateral recipient veins are unavailable. Option C (venous cross-over to contralateral flap vein) is a recognized microsurgical salvage technique in this specific situation, offering a new outflow pathway. Alternatives are inferior: A (shortening pedicle) doesn't solve recipient vein shortage; B (retrograde IMV with another graft) adds complexity and failure risk; D (conversion to pedicled TRAM) is not feasible after free flap harvest; E (immediate removal) is a last resort, not the highest likelihood salvage. Medical accuracy is sound; the logic supports a single best answer.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\": \n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: free flap with venous graft, postoperative venous congestion (swelling, violaceous discoloration, brisk bleeding on pinprick, no venous signal), patent arterial anastomosis, thrombotic venous graft, limited nearby recipient veins, contralateral internal mammary and thoracodorsal systems already occupied. The scenario uniquely points to venous outflow salvage when ipsilateral recipient veins are unavailable. Option C (venous cross-over to contralateral flap vein) is a recognized microsurgical salvage technique in this specific situation, offering a new outflow pathway. Alternatives are inferior: A (shortening pedicle) doesn't solve recipient vein shortage; B (retrograde IMV with another graft) adds complexity and failure risk; D (conversion to pedicled TRAM) is not feasible after free flap harvest; E (immediate removal) is a last resort, not the highest likelihood salvage. Medical accuracy is sound; the logic supports a single best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-002", "question": "A 56-year-old man presents with progressive gait ataxia, urinary urgency, and cognitive slowing over 10 months. MRI shows ventriculomegaly out of proportion to mild cortical atrophy, but in addition there is a subtle nodular T1-hypointense, T2-hyperintense lesion in the posterior third ventricle near the aqueduct, with minimal enhancement and no diffusion restriction. Cine phase-contrast MRI demonstrates preserved CSF stroke volume at the cerebral aqueduct. A high-volume lumbar tap test produces only transient, equivocal improvement. Which is the most appropriate next neurosurgical management?", "options": ["Programmable ventriculoperitoneal shunt placement without further workup, given classic normal-pressure hydrocephalus symptoms", "Endoscopic third ventriculostomy with concurrent biopsy of the third ventricular lesion", "Endoscopic biopsy and possible debulking of the third ventricular lesion without CSF diversion, followed by observation", "Stereotactic radiosurgery targeted to the third ventricular lesion followed by reassessment of hydrocephalus", "External lumbar drainage trial over 72 hours before deciding on shunt placement"], "answer": "B", "answer_index": 1, "explanation": "The combination of ventriculomegaly and a small obstructive-appearing lesion near the aqueduct suggests a secondary obstructive hydrocephalus rather than idiopathic NPH; ETV addresses obstruction and allows tissue diagnosis for a possible low-grade tumor or colloid-like lesion. Shunting alone (A, E) ignores a likely focal obstructive cause and risks shunt dependence. Biopsy alone (C) does not treat hydrocephalus. SRS (D) is premature without histology and does not immediately relieve CSF obstruction.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: Progressive NPH-like symptoms (gait ataxia, urinary urgency, cognitive slowing), ventriculomegaly out of proportion to atrophy, but with a subtle nodular lesion near the aqueduct (T1-hypo/T2-hyper, minimal enhancement, no diffusion restriction) suggesting a focal obstructive cause. Preserved CSF stroke volume at the aqueduct on cine MRI argues against a simple aqueductal stenosis, and high-volume tap test gave only transient/equivocal improvement, making idiopathic NPH less likely. The lesion is the key feature driving need for both CSF diversion (addressing obstruction) and tissue diagnosis. Main logical issue: None; the lesion location and characteristics logically point to endoscopic third ventriculostomy with biopsy as the most appropriate next neurosurgical step, integrating diagnosis and treatment. Main medical accuracy issue: None; the reasoning aligns with standard neurosurgical principles for symptomatic obstructive hydrocephalus with an unidentified intraventricular lesion. Minimal fix: None required for logical validity; to enhance clarity, the stem could explicitly state the lesion is causing aqueductal compression/obstruction.\", \"logical_false_reason\": \"T\", \"logical_validity\": true, \"medical_accuracy_score\":  \"5\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: Progressive NPH-like symptoms (gait ataxia, urinary urgency, cognitive slowing), ventriculomegaly out of proportion to atrophy, but with a subtle nodular lesion near the aqueduct (T1-hypo/T2-hyper, minimal enhancement, no diffusion restriction) suggesting a focal obstructive cause. Preserved CSF stroke volume at the aqueduct on cine MRI argues against a simple aqueductal stenosis, and high-volume tap test gave only transient/equivocal improvement, making idiopathic NPH less likely. The lesion is the key feature driving need for both CSF diversion (addressing obstruction) and tissue diagnosis. Main logical issue: None; the lesion location and characteristics logically point to endoscopic third ventriculostomy with biopsy as the most appropriate next neurosurgical step, integrating diagnosis and treatment. Main medical accuracy issue: None; the reasoning aligns with standard neurosurgical principles for symptomatic obstructive hydrocephalus with an unidentified intraventricular lesion. Minimal fix: None required for logical validity; to enhance clarity, the stem could explicitly state the lesion is causing aqueductal compression/obstruction.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-003", "question": "A 68-year-old man with cT3N1M0 distal esophageal adenocarcinoma receives neoadjuvant chemoradiation with carboplatin/paclitaxel and 50.4 Gy in 28 fractions using IMRT. He has severe baseline interstitial lung disease (UIP pattern) with DLCO 35% predicted. At multidisciplinary review before simulation, the radiation oncologist must choose a planning goal that most reduces the risk of fatal radiation pneumonitis while still allowing adequate target coverage. Which constraint is most critical to prioritize in this scenario?", "options": ["Mean lung dose (MLD) <10 Gy, even if heart V40 increases modestly", "Total lung V20 <20%, accepting an MLD up to 15 Gy", "Ipsilateral lung V30 <15% with no specific constraint on contralateral lung", "Total lung V5 <40% while relaxing V20 and MLD constraints", "Heart V30 <30% with no further reduction in lung dose beyond standard constraints"], "answer": "A", "answer_index": 0, "explanation": "In patients with severe underlying ILD, data show the mean lung dose is the best single predictor of lethal pneumonitis; keeping MLD as low as possible (often <10 Gy) is paramount, even if cardiac doses increase somewhat. V20 (B) is important but less predictive in ILD compared with MLD. Ipsilateral V30 constraints (C) and V5 (D) are less strongly tied to high-grade pneumonitis. Prioritizing heart sparing (E) over lung constraints is inappropriate in a patient at extreme pulmonary risk.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: severe interstitial lung disease (UIP pattern, DLCO 35% predicted) and the goal to most reduce risk of fatal radiation pneumonitis while allowing adequate target coverage. The stem clearly establishes extreme pulmonary vulnerability, making lung dose minimization the overriding priority. The item logically directs selection of the constraint most strongly associated with fatal pneumonitis in ILD. Main logical issue: None; the stem provides sufficient discriminatory detail (severe ILD) to prioritize MLD. Main medical accuracy issue: None; the emphasis on MLD in severe ILD is consistent with oncologic literature and clinical practice. Minimal fix: None required; the item is unambiguous and accurate as written.\",\n  \"medical_accuracy_score\":  \"5\",\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: severe interstitial lung disease (UIP pattern, DLCO 35% predicted) and the goal to most reduce risk of fatal radiation pneumonitis while allowing adequate target coverage. The stem clearly establishes extreme pulmonary vulnerability, making lung dose minimization the overriding priority. The item logically directs selection of the constraint most strongly associated with fatal pneumonitis in ILD. Main logical issue: None; the stem provides sufficient discriminatory detail (severe ILD) to prioritize MLD. Main medical accuracy issue: None; the emphasis on MLD in severe ILD is consistent with oncologic literature and clinical practice. Minimal fix: None required; the item is unambiguous and accurate as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-004", "question": "A 63-year-old woman undergoes right upper lobectomy via VATS for a 2.8-cm peripheral squamous cell carcinoma. On postoperative day 5 she develops acute dyspnea and subcutaneous emphysema. Chest CT shows a large posterior membranous tracheal defect 2 cm above the carina communicating with a loculated right pleural air collection. Bronchoscopy confirms a 1.5-cm full-thickness laceration with necrotic edges in a fragile, steroid-exposed airway. The right main bronchus is intact; there is no mediastinitis and she is hemodynamically stable but ventilator dependent. Which operative strategy provides the best chance of durable repair and respiratory recovery?", "options": ["Primary end-to-end tracheal resection with anastomosis and neck flexion, without tissue interposition", "Right posterolateral thoracotomy with direct tracheal defect closure reinforced by a pedicled intercostal muscle flap", "Cervical approach with placement of a covered tracheal stent and no open repair", "Right thoracotomy with tracheal defect closure buttressed by a pedicled latissimus dorsi flap and distal tracheostomy below the repair", "Clamshell thoracotomy with carinal resection and reconstruction to isolate the injured segment"], "answer": "B", "answer_index": 1, "explanation": "A posterior distal tracheal laceration communicating with the ipsilateral pleura after lobectomy is best approached via thoracotomy with direct repair and vascularized intercostal muscle buttress, preserving remaining lung and avoiding extensive resection. Circumferential resection (A, E) is excessive and risky in a fragile airway. Covered stenting alone (C) in a full-thickness laceration with necrotic edges risks dehiscence and mediastinitis. Latissimus flap plus distal tracheostomy (D) is more morbid and generally unnecessary compared with intercostal muscle reinforcement.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: acute dyspnea/subcutaneous emphysema post-VATS lobectomy; CT shows posterior membranous tracheal defect 2 cm above carina communicating with right pleural air; bronchoscopy shows 1.5-cm full-thickness laceration with necrotic edges in fragile, steroid-exposed airway; right main bronchus intact; no mediastinitis; hemodynamically stable but ventilator dependent. The findings point to a post-lobectomy tracheal injury (likely from stapler or dissection) with tissue compromise, requiring durable repair. Logical issue: None; stem provides sufficient detail for discrimination. Medical accuracy: The keyed answer (thoracotomy with direct closure and intercostal muscle flap) aligns with thoracic surgery principles for traumatic tracheal lacerations with tissue loss: direct repair with vascularized tissue reinforcement is standard, avoiding excessive resection or stenting alone in a contaminated field. Minor nuance: 'Steroid-exposed airway' implies poor healing, strengthening need for vascularized flap. Minimal fix: None needed; item is clear and accurate.\", \"logical_false_reason\": \"T\", \"logical_validity\": true, \"medical_accuracy_score\":  \"4\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: acute dyspnea/subcutaneous emphysema post-VATS lobectomy; CT shows posterior membranous tracheal defect 2 cm above carina communicating with right pleural air; bronchoscopy shows 1.5-cm full-thickness laceration with necrotic edges in fragile, steroid-exposed airway; right main bronchus intact; no mediastinitis; hemodynamically stable but ventilator dependent. The findings point to a post-lobectomy tracheal injury (likely from stapler or dissection) with tissue compromise, requiring durable repair. Logical issue: None; stem provides sufficient detail for discrimination. Medical accuracy: The keyed answer (thoracotomy with direct closure and intercostal muscle flap) aligns with thoracic surgery principles for traumatic tracheal lacerations with tissue loss: direct repair with vascularized tissue reinforcement is standard, avoiding excessive resection or stenting alone in a contaminated field. Minor nuance: 'Steroid-exposed airway' implies poor healing, strengthening need for vascularized flap. Minimal fix: None needed; item is clear and accurate.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-005", "question": "A 72-year-old man with prior left common femoral endarterectomy and iliac stenting presents with limb-threatening ischemia of the left leg (Rutherford class 5). Angiography shows occluded left external iliac stent and a heavily calcified common femoral artery with poor clamp sites. The profunda femoris is patent with robust collaterals; the superficial femoral artery (SFA) is chronically occluded. Aortobifemoral bypass is contraindicated due to prior hostile laparotomy and significant cardiopulmonary comorbidity. Which revascularization strategy most reliably restores durable inflow to the profunda with acceptable operative risk?", "options": ["Endovascular recanalization and relining of the external iliac stent only, without addressing the common femoral artery", "Retroperitoneal ilio-profunda bypass from the ipsilateral common iliac artery to the profunda femoris artery", "Axillo-bifemoral bypass using an 8-mm ringed PTFE graft with proximal hood anastomosis to the axillary artery", "Femoral-femoral crossover bypass from the contralateral common femoral artery to the ipsilateral profunda femoris artery", "Hybrid repair with endovascular iliac stent relining plus open common femoral endarterectomy and patch angioplasty to the profunda origin"], "answer": "E", "answer_index": 4, "explanation": "A hybrid approach-iliac stent relining to restore inflow plus open common femoral endarterectomy/patch to the profunda-directly corrects both inflow and the key outflow vessel while avoiding aortic surgery. Isolated iliac relining (A) leaves the diseased CFA uncorrected. Ilio-profunda bypass (B) is more invasive than necessary in a hostile abdomen. Axillo-bifemoral (C) and fem-fem crossover (D) ignore the ipsilateral inflow lesion and are less durable or anatomically suboptimal in this context.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: limb-threatening ischemia (Rutherford 5), occluded external iliac stent, heavily calcified common femoral artery with poor clamp sites, patent profunda with robust collaterals, chronically occluded SFA, contraindications to aortobifemoral bypass (hostile abdomen, cardiopulmonary risk). The question asks for a strategy that reliably restores durable inflow to the profunda with acceptable risk. The hybrid approach (E) directly addresses both the inflow (iliac stent occlusion) and outflow (common femoral disease) lesions, which is necessary for durable revascularization. Isolated iliac relining (A) leaves the diseased common femoral artery untreated, risking failure. Ilio-profunda bypass (B) is more invasive in a hostile abdomen. Axillo-bifemoral (C) and femoral-femoral crossover (D) ignore the ipsilateral inflow lesion and are less durable or anatomically suboptimal. No contradictions or underspecification; the key is defensible as the single best answer. Medical accuracy is consistent with current vascular surgery principles. Minimal fix: None required; item is clear and accurate.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\": \n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: limb-threatening ischemia (Rutherford 5), occluded external iliac stent, heavily calcified common femoral artery with poor clamp sites, patent profunda with robust collaterals, chronically occluded SFA, contraindications to aortobifemoral bypass (hostile abdomen, cardiopulmonary risk). The question asks for a strategy that reliably restores durable inflow to the profunda with acceptable risk. The hybrid approach (E) directly addresses both the inflow (iliac stent occlusion) and outflow (common femoral disease) lesions, which is necessary for durable revascularization. Isolated iliac relining (A) leaves the diseased common femoral artery untreated, risking failure. Ilio-profunda bypass (B) is more invasive in a hostile abdomen. Axillo-bifemoral (C) and femoral-femoral crossover (D) ignore the ipsilateral inflow lesion and are less durable or anatomically suboptimal. No contradictions or underspecification; the key is defensible as the single best answer. Medical accuracy is consistent with current vascular surgery principles. Minimal fix: None required; item is clear and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-006", "question": "A 45-year-old woman with a 1.7-cm left adrenal incidentaloma has mild hypertension and intermittent headaches. She is on a thiazide diuretic. Labs show: K 3.3 mmol/L, plasma aldosterone 15 ng/dL, plasma renin activity 0.1 ng/mL/h (suppressed), and aldosterone-renin ratio (ARR) of 150 (elevated). Confirmatory saline suppression test is borderline. Adrenal vein sampling (AVS) without cosyntropin stimulation reveals: cortisol-corrected aldosterone lateralization index (LI) of 2.2, but contralateral suppression index <0.3. Which is the most appropriate next step in management?", "options": ["Left laparoscopic adrenalectomy, given imaging-concordant unilateral lesion and contralateral suppression", "Continue medical therapy with mineralocorticoid receptor antagonists because lateralization index is below traditional cutoff", "Repeat AVS with cosyntropin stimulation to clarify lateralization before deciding on surgery", "Proceed to partial (cortical-sparing) resection of the left adrenal nodule to preserve adrenal function", "Observation without intervention, as results suggest nonfunctioning incidentaloma"], "answer": "A", "answer_index": 0, "explanation": "Current AVS interpretation emphasizes both lateralization and contralateral suppression; a low contralateral aldosterone/cortisol ratio (<0.3) strongly indicates unilateral disease even with modest LI, especially with concordant imaging and biochemical primary aldosteronism. Medical therapy (B) or observation (E) ignores resectable unilateral disease. Repeating AVS (C) is unnecessary given clear suppression. Partial adrenalectomy (D) is not standard for unilateral aldosterone-producing adenomas and risks recurrence.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Endocrine", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: adrenal incidentaloma with biochemical primary aldosteronism (elevated ARR, suppressed renin, borderline saline suppression), imaging-concordant left adrenal lesion, AVS shows lateralization index (LI) 2.2 (modest but >2.0) and contralateral suppression index <0.3. The item emphasizes that current AVS interpretation values contralateral suppression as a strong indicator of unilateral disease, supporting surgery despite modest LI. Main logical issue: None; the stem provides sufficient data for a unique best answer. Main medical accuracy issue: The item's teaching point aligns with modern nuanced AVS interpretation (considering both lateralization and contralateral suppression) and standard management guidelines for unilateral primary aldosteronism. Minimal fix: None required; the item is clear and accurate as written.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\": \n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: adrenal incidentaloma with biochemical primary aldosteronism (elevated ARR, suppressed renin, borderline saline suppression), imaging-concordant left adrenal lesion, AVS shows lateralization index (LI) 2.2 (modest but >2.0) and contralateral suppression index <0.3. The item emphasizes that current AVS interpretation values contralateral suppression as a strong indicator of unilateral disease, supporting surgery despite modest LI. Main logical issue: None; the stem provides sufficient data for a unique best answer. Main medical accuracy issue: The item's teaching point aligns with modern nuanced AVS interpretation (considering both lateralization and contralateral suppression) and standard management guidelines for unilateral primary aldosteronism. Minimal fix: None required; the item is clear and accurate as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-007", "question": "A 63-year-old man with compensated cirrhosis (Child-Pugh A, MELD 9) has a 2.3-cm hepatocellular carcinoma (HCC) in segment VII adjacent to the right hepatic vein and diaphragm. He has portal hypertension with platelets 70,000/µL, small varices, and HVPG 13 mmHg. Liver function is preserved; he is not yet listed for transplant due to social issues. Which management offers the best balance of long-term oncologic control and hepatic reserve preservation?", "options": ["Open right posterior sectionectomy including segment VII and part of VIII", "Laparoscopic wedge resection of segment VII tumor with Pringle maneuver", "Ultrasound-guided percutaneous radiofrequency ablation (RFA) of the lesion", "Transarterial chemoembolization (TACE) followed by reassessment for ablation or resection", "Listing for liver transplantation without locoregional therapy until a donor becomes available"], "answer": "C", "answer_index": 2, "explanation": "For a solitary ≤3-cm HCC in a cirrhotic liver with significant portal hypertension and thrombocytopenia, percutaneous ablation achieves local control comparable to resection with lower risk of hepatic decompensation. Major or even limited resection (A, B) carries high risk in portal hypertension (HVPG >10 mmHg). TACE (D) is inferior to curative-intent ablation for small lesions. Delayed transplant without bridging (E) risks progression beyond criteria and prevents near-term curative local control.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: solitary 2.3 cm HCC in Child-Pugh A cirrhosis, portal hypertension (HVPG 13 mmHg, platelets 70k), tumor adjacent to right hepatic vein/diaphragm, patient not yet listed for transplant. The item uniquely supports percutaneous RFA (C) as best: ablation is guideline-recommended first-line curative therapy for small (<3 cm) HCC in cirrhosis with portal hypertension, balancing oncologic control (comparable to resection for small tumors) and preservation of hepatic reserve (lower decompensation risk vs. resection A/B). TACE (D) is not first-line curative for this small lesion. Transplant listing without bridging (E) risks progression. No logical contradictions; key matches standard care. Medical accuracy is sound. Minimal fix: none needed; item is clear and accurate.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: solitary 2.3 cm HCC in Child-Pugh A cirrhosis, portal hypertension (HVPG 13 mmHg, platelets 70k), tumor adjacent to right hepatic vein/diaphragm, patient not yet listed for transplant. The item uniquely supports percutaneous RFA (C) as best: ablation is guideline-recommended first-line curative therapy for small (<3 cm) HCC in cirrhosis with portal hypertension, balancing oncologic control (comparable to resection for small tumors) and preservation of hepatic reserve (lower decompensation risk vs. resection A/B). TACE (D) is not first-line curative for this small lesion. Transplant listing without bridging (E) risks progression. No logical contradictions; key matches standard care. Medical accuracy is sound. Minimal fix: none needed; item is clear and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-008", "question": "A 39-year-old man presents with recurrent pancreatitis and is found to have a 2.5-cm enhancing mass in the pancreatic head that encases the intrapancreatic common bile duct, with upstream dilatation but no vascular involvement. EUS-FNA is nondiagnostic twice. CA 19-9 is normal. IgG4 level is mildly elevated at 180 mg/dL (ULN 135). CT shows a capsule-like rim around the lesion and diffuse, sausage-shaped enlargement of the gland. Which management approach is most appropriate?", "options": ["Trial of high-dose corticosteroids with close radiologic follow-up before considering surgery", "Pancreaticoduodenectomy because focal autoimmune pancreatitis cannot be reliably distinguished from adenocarcinoma", "Repeat EUS-FNA with core needle and flow cytometry to exclude lymphoma", "Observation alone with serial imaging in 6 months given low CA 19-9 and mild symptoms", "ERCP with biliary brushing cytology and stent placement, with surgery only if cytology is positive"], "answer": "A", "answer_index": 0, "explanation": "Imaging findings (capsule-like rim, sausage-shaped gland) and elevated IgG4 strongly suggest type 1 autoimmune pancreatitis; a steroid trial with close monitoring is accepted to avoid unnecessary Whipple when malignancy is not strongly supported. Immediate pancreaticoduodenectomy (B) is premature. Repeat biopsy (C) is less helpful given characteristic features. Observation alone (D) ignores ongoing pancreatitis and biliary obstruction. ERCP cytology (E) has low sensitivity and does not treat underlying inflammatory disease.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: recurrent pancreatitis, 2.5-cm pancreatic head mass encasing CBD with upstream dilatation, no vascular involvement, nondiagnostic EUS-FNA, normal CA 19-9, mildly elevated IgG4 (180 mg/dL), CT showing capsule-like rim and diffuse sausage-shaped gland enlargement. These classic imaging and serologic features strongly favor type 1 autoimmune pancreatitis (AIP) over malignancy. Main logical issue: None; the vignette provides sufficient discriminators (IgG4 elevation, characteristic CT findings, normal tumor marker) to uniquely support a steroid trial as the most appropriate initial management, avoiding premature surgery. Main medical accuracy issue: None; the approach aligns with consensus guidelines for suspected AIP. Minimal fix: None required; the item is well-constructed.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: recurrent pancreatitis, 2.5-cm pancreatic head mass encasing CBD with upstream dilatation, no vascular involvement, nondiagnostic EUS-FNA, normal CA 19-9, mildly elevated IgG4 (180 mg/dL), CT showing capsule-like rim and diffuse sausage-shaped gland enlargement. These classic imaging and serologic features strongly favor type 1 autoimmune pancreatitis (AIP) over malignancy. Main logical issue: None; the vignette provides sufficient discriminators (IgG4 elevation, characteristic CT findings, normal tumor marker) to uniquely support a steroid trial as the most appropriate initial management, avoiding premature surgery. Main medical accuracy issue: None; the approach aligns with consensus guidelines for suspected AIP. Minimal fix: None required; the item is well-constructed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-009", "question": "A 26-year-old man presents with splenomegaly, hemoglobin 9.8 g/dL, platelets 130,000/µL, and leukocytes 5,200/µL. Peripheral smear shows tear-drop cells and leukoerythroblastosis. Bone marrow biopsy is markedly fibrotic with 1-2% blasts; JAK2, CALR, and MPL mutations are negative; next-generation sequencing reveals an isolated ASXL1 mutation. Cytogenetics are normal. He is transfusion independent but symptomatic from splenomegaly. DIPSS-plus score indicates intermediate-2 risk primary myelofibrosis. His 10/10 HLA-matched sibling donor is available. Which is the most appropriate management strategy?", "options": ["Begin ruxolitinib and defer allogeneic stem cell transplantation until he becomes transfusion dependent", "Proceed to allogeneic stem cell transplantation in first chronic phase despite triple-negative driver status", "Observation with serial monitoring; ASXL1 mutation alone does not justify early transplant", "Splenectomy followed by hydroxyurea cytoreduction to delay transplantation", "Ruxolitinib bridge therapy for 3-6 months to reduce spleen size, then proceed to planned allogeneic transplantation"], "answer": "E", "answer_index": 4, "explanation": "Intermediate-2 risk myelofibrosis in a young patient with an available donor warrants allogeneic transplant; bridging with ruxolitinib can reduce spleen size and improve conditioning tolerance without compromising transplant timing. Deferring transplant (A, C) risks disease progression. Splenectomy (D) before transplant is reserved for select cases due to morbidity. Immediate transplant without JAK inhibitor optimization (B) may lead to worse peri-transplant outcomes in massively enlarged spleens.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Hematology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: young patient (26), intermediate-2 risk primary myelofibrosis (per DIPSS-plus), symptomatic splenomegaly, available HLA-matched sibling donor, triple-negative driver mutation status but isolated ASXL1 mutation (adverse prognostic marker). The stem clearly sets up a scenario where allogeneic stem cell transplantation is indicated due to risk category and age, and the question asks for the most appropriate management strategy. The keyed answer (E) recommends ruxolitinib bridge therapy followed by planned transplantation, which aligns with current guidelines: JAK inhibitor bridging to reduce spleen size and symptoms prior to transplant is a standard approach to improve transplant outcomes. Main logical issue: None; the stem provides sufficient detail to discriminate among options. Main medical accuracy issue: None; the logic is consistent with current NCCN/ELN guidelines for myelofibrosis. Minimal fix: None required; the item is well-constructed.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\": \n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: young patient (26), intermediate-2 risk primary myelofibrosis (per DIPSS-plus), symptomatic splenomegaly, available HLA-matched sibling donor, triple-negative driver mutation status but isolated ASXL1 mutation (adverse prognostic marker). The stem clearly sets up a scenario where allogeneic stem cell transplantation is indicated due to risk category and age, and the question asks for the most appropriate management strategy. The keyed answer (E) recommends ruxolitinib bridge therapy followed by planned transplantation, which aligns with current guidelines: JAK inhibitor bridging to reduce spleen size and symptoms prior to transplant is a standard approach to improve transplant outcomes. Main logical issue: None; the stem provides sufficient detail to discriminate among options. Main medical accuracy issue: None; the logic is consistent with current NCCN/ELN guidelines for myelofibrosis. Minimal fix: None required; the item is well-constructed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-010", "question": "A 31-year-old woman with systemic lupus erythematosus, class IV lupus nephritis, and high-titer anti-dsDNA presents with a 4-week history of progressive symmetric lower extremity weakness, areflexia, and sensory loss. NCS/EMG show a demyelinating polyneuropathy consistent with CIDP. She is on prednisone 10 mg daily and hydroxychloroquine. Creatinine is 1.3 mg/dL; she has nephrotic-range proteinuria. Which immunologic treatment strategy best balances disease control and long-term toxicity?", "options": ["High-dose IV methylprednisolone pulses followed by oral prednisone 1 mg/kg for both CIDP and lupus nephritis", "IVIG monthly for CIDP plus increase prednisone to 0.5 mg/kg, with no other agents", "Rituximab-based regimen targeting both CIDP and lupus nephritis with tapering of steroids", "Cyclophosphamide induction followed by azathioprine maintenance for lupus and CIDP", "Plasma exchange for CIDP plus mycophenolate mofetil for lupus nephritis"], "answer": "C", "answer_index": 2, "explanation": "Rituximab has efficacy in both CIDP (especially autoimmune-mediated forms) and proliferative lupus nephritis, allowing steroid sparing and addressing shared B-cell pathogenesis. High-dose steroids alone (A, B) worsen long-term toxicity and may be insufficient for nephritis. Cyclophosphamide (D) carries more gonadal and malignancy risk in a young woman. Plasmapheresis (E) gives transient CIDP benefit but does not control chronic B-cell-driven lupus nephritis as effectively as rituximab-based regimens.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: patient with SLE, class IV lupus nephritis, and CIDP (demyelinating polyneuropathy) requiring an immunologic treatment that controls both conditions while minimizing long-term toxicity. Rituximab (C) is a B-cell-targeted therapy with evidence for both refractory lupus nephritis and autoimmune neuropathies like CIDP, allowing steroid tapering. Alternatives are less optimal: high-dose steroids (A, B) increase toxicity and may inadequately control nephritis; cyclophosphamide (D) has higher gonadal/malignancy risk in a young woman; plasma exchange (E) is transient for CIDP and doesn't address chronic nephritis as effectively. No logical contradictions; the item supports a unique best answer. Medical accuracy is sound, aligning with current guidelines for refractory SLE/CIDP overlap. Minimal fix: none needed for validity; to enhance clarity, specify 'refractory' or 'steroid-dependent' CIDP to underscore rituximab's role.\",\n  \"medical_accuracy_score\":  \"4\",\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: patient with SLE, class IV lupus nephritis, and CIDP (demyelinating polyneuropathy) requiring an immunologic treatment that controls both conditions while minimizing long-term toxicity. Rituximab (C) is a B-cell-targeted therapy with evidence for both refractory lupus nephritis and autoimmune neuropathies like CIDP, allowing steroid tapering. Alternatives are less optimal: high-dose steroids (A, B) increase toxicity and may inadequately control nephritis; cyclophosphamide (D) has higher gonadal/malignancy risk in a young woman; plasma exchange (E) is transient for CIDP and doesn't address chronic nephritis as effectively. No logical contradictions; the item supports a unique best answer. Medical accuracy is sound, aligning with current guidelines for refractory SLE/CIDP overlap. Minimal fix: none needed for validity; to enhance clarity, specify 'refractory' or 'steroid-dependent' CIDP to underscore rituximab's role.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-011", "question": "A 27-year-old woman sustains a severe crush-avulsion injury to her dominant right forearm in an industrial press. There is segmental loss of the ulnar artery, ulnar nerve (6 cm gap at the wrist), and extensive soft-tissue loss over the volar-ulnar forearm with exposed flexor tendons; radial artery and median nerve are intact. Hand perfusion is marginal via the radial artery. Debridement leaves a 12 × 8 cm wound and nonrepairable FDS/FDP to ring and small fingers. Considering function and reconstructive ladder, what is the optimal reconstructive strategy in a single stage?", "options": ["Local rotational fasciocutaneous flap with reversed interpositional saphenous vein graft for ulnar artery and autologous sural nerve cable grafts for ulnar nerve", "Free anterolateral thigh (ALT) flap with flow-through reconstruction of the ulnar artery and nerve coaptation via sural nerve graft", "Split-thickness skin graft over the exposed tendons after tendon shortening and radial artery-only perfusion", "Pedicled groin flap for soft-tissue coverage and delayed ulnar nerve grafting once the wound bed is stable", "Free radial forearm flap from the contralateral limb including cephalic vein for venous outflow and ulnar nerve primary end-to-end repair under tension"], "answer": "B", "answer_index": 1, "explanation": "A free ALT flap can provide robust soft-tissue coverage and can be configured as a flow-through flap to reconstitute the ulnar artery while allowing concurrent ulnar nerve cable grafting, optimizing perfusion and nerve regeneration in one stage. Local rotational flaps (A) are insufficient for the large defect and lack flow-through capabilities. Skin graft alone (C) is inadequate over exposed tendons and does not restore artery/nerve. Staged groin flap (D) delays nerve repair. A contralateral radial forearm flap (E) sacrifices a major artery and cannot provide tension-free primary nerve repair.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: severe crush-avulsion injury with segmental loss of ulnar artery and nerve (6 cm gap), large soft-tissue defect (12 × 8 cm), exposed tendons, marginal hand perfusion via radial artery, and nonrepairable flexor tendons. The question asks for the optimal single-stage reconstructive strategy considering function and the reconstructive ladder. Option B (free ALT flap with flow-through ulnar artery reconstruction and nerve grafting) uniquely addresses all critical needs: robust soft-tissue coverage, arterial reconstruction to improve perfusion, and immediate nerve repair. Alternatives are inferior: A (local flap) is insufficient for defect size and lacks reliable arterial reconstruction; C (skin graft) fails over exposed tendons and ignores vascular/nerve deficits; D (staged approach) delays nerve repair; E (contralateral radial forearm flap) sacrifices a major artery and risks tension on nerve repair. No contradictions or missing details; medical accuracy aligns with reconstructive surgery principles. Minimal fix: none required.\",\n  \"medical_accuracy_score\":  \"5\",\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: severe crush-avulsion injury with segmental loss of ulnar artery and nerve (6 cm gap), large soft-tissue defect (12 × 8 cm), exposed tendons, marginal hand perfusion via radial artery, and nonrepairable flexor tendons. The question asks for the optimal single-stage reconstructive strategy considering function and the reconstructive ladder. Option B (free ALT flap with flow-through ulnar artery reconstruction and nerve grafting) uniquely addresses all critical needs: robust soft-tissue coverage, arterial reconstruction to improve perfusion, and immediate nerve repair. Alternatives are inferior: A (local flap) is insufficient for defect size and lacks reliable arterial reconstruction; C (skin graft) fails over exposed tendons and ignores vascular/nerve deficits; D (staged approach) delays nerve repair; E (contralateral radial forearm flap) sacrifices a major artery and risks tension on nerve repair. No contradictions or missing details; medical accuracy aligns with reconstructive surgery principles. Minimal fix: none required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-012", "question": "A 54-year-old man with a 2.2-cm pituitary macroadenoma causing acromegaly undergoes endoscopic endonasal resection. Postoperative day 1 labs show serum sodium 142 mmol/L and urine output 3.5 L/day. On day 7, sodium is 128 mmol/L with serum osmolality 265 mOsm/kg and urine osmolality 600 mOsm/kg; he is clinically euvolemic. Morning cortisol is 15 µg/dL. On day 12, sodium falls to 118 mmol/L despite fluid restriction, and he becomes confused; serum osmolality 250 mOsm/kg, urine osmolality 750 mOsm/kg. MRI shows no new findings. Which mechanism best explains this delayed worsening hyponatremia?", "options": ["Persistent syndrome of inappropriate antidiuretic hormone secretion (SIADH) from hypothalamic neuronal injury", "Triphasic water balance disorder with transition from SIADH phase to late-phase permanent diabetes insipidus", "Cerebral salt wasting due to subclinical subarachnoid hemorrhage during surgery", "Reset osmostat due to chronic hyponatremia from preoperative growth hormone excess", "Glucocorticoid deficiency from delayed postoperative hypopituitarism"], "answer": "A", "answer_index": 0, "explanation": "The typical triphasic pattern after pituitary surgery is early DI, then SIADH-related hyponatremia around days 5-10; persistent, severe, euvolemic hyponatremia with high urine osmolality is most consistent with sustained SIADH. Transition to DI (B) would cause hypernatremia and dilute urine. Cerebral salt wasting (C) would show hypovolemia and high urine sodium but is rare here. Reset osmostat (D) would not present with acute confusion at Na 118. Cortisol deficiency (E) is unlikely with normal morning cortisol.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: Delayed hyponatremia (day 7) with euvolemia, high urine osmolality, normal cortisol, and no MRI changes initially suggests SIADH. However, the worsening hyponatremia on day 12 despite fluid restriction, with further increased urine osmolality (750 mOsm/kg) and confusion, is inconsistent with persistent SIADH, as fluid restriction should improve SIADH. The triphasic pattern (B) describes transition from SIADH to DI, which would cause dilute urine and hypernatremia, not the observed high urine osmolality and worsening hyponatremia. Main logical issue: The key (A) is not the best answer given the failure of fluid restriction and the timeline; the most consistent mechanism is not clearly defensible among options. Main medical accuracy issue: The vignette's description of worsening hyponatremia despite fluid restriction challenges the SIADH diagnosis, as fluid restriction is first-line for SIADH and should prevent progression. Minimal fix: Clarify the response to fluid restriction (e.g., 'sodium stabilizes with fluid restriction') to support persistent SIADH, or adjust the key to reflect a more plausible mechanism like triphasic transition with a mixed picture.\", \"logical_false_reason\": \"K\", \"logical_validity\": false, \"medical_accuracy_score\":  \"3\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: Delayed hyponatremia (day 7) with euvolemia, high urine osmolality, normal cortisol, and no MRI changes initially suggests SIADH. However, the worsening hyponatremia on day 12 despite fluid restriction, with further increased urine osmolality (750 mOsm/kg) and confusion, is inconsistent with persistent SIADH, as fluid restriction should improve SIADH. The triphasic pattern (B) describes transition from SIADH to DI, which would cause dilute urine and hypernatremia, not the observed high urine osmolality and worsening hyponatremia. Main logical issue: The key (A) is not the best answer given the failure of fluid restriction and the timeline; the most consistent mechanism is not clearly defensible among options. Main medical accuracy issue: The vignette's description of worsening hyponatremia despite fluid restriction challenges the SIADH diagnosis, as fluid restriction is first-line for SIADH and should prevent progression. Minimal fix: Clarify the response to fluid restriction (e.g., 'sodium stabilizes with fluid restriction') to support persistent SIADH, or adjust the key to reflect a more plausible mechanism like triphasic transition with a mixed picture.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-013", "question": "A 69-year-old man with T2N0M0 glottic squamous cell carcinoma extending to the anterior commissure is planned for definitive radiotherapy. He is a heavy smoker with severe COPD and cannot tolerate prolonged immobilization. The radiation oncologist must choose the optimal fractionation regimen to maximize local control while minimizing acute laryngeal edema and long-term dysphagia. Which regimen best balances these goals?", "options": ["Conventional 2.0 Gy per fraction to 70 Gy over 7 weeks", "Hypofractionated 2.25 Gy per fraction to 63 Gy over 5.6 weeks", "Hyperfractionated 1.2 Gy twice daily to 79.2 Gy total dose", "Concomitant boost regimen with 1.8 Gy daily plus 1.5 Gy second daily fraction in the final 3 weeks", "Stereotactic body radiotherapy (SBRT) 7.5 Gy × 5 fractions to the glottic larynx"], "answer": "B", "answer_index": 1, "explanation": "For early to select T2 glottic cancers, modest hypofractionation (e.g., 2.25 Gy/fraction to ~63 Gy) improves local control with acceptable toxicity and shorter overall treatment time, particularly useful in patients with limited tolerance for prolonged immobilization. Conventional fractionation (A) is effective but less optimal in control and time. Hyperfractionation (C) and concomitant boost (D) increase mucosal toxicity. SBRT (E) for glottic cancer remains investigational with concerns about cartilage necrosis and voice quality.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. The stem describes a T2N0M0 glottic SCC extending to anterior commissure, with severe COPD and intolerance to prolonged immobilization. The key discriminating factors are need for high local control, minimizing acute edema/long-term dysphagia, and shorter treatment time. For T2 glottic cancer with anterior commissure involvement, hyperfractionated radiotherapy (option C) is often recommended in guidelines (e.g., RTOG 9512) to improve local control while managing toxicity, and it fits the goal of balancing control and toxicity. Hypofractionation (B) is used for early glottic cancer but for T2 with anterior commissure extension, hyperfractionation is typically preferred. Option B is not the best-supported choice; C is more defensible. Main logical issue: key mismatch. Main medical accuracy: minor nuance—hypofractionation is acceptable for T1, but for T2 with anterior commissure, hyperfractionation is often favored. Minimal fix: Change key to C or adjust stem to specify T1 disease.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\": \n    \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. The stem describes a T2N0M0 glottic SCC extending to anterior commissure, with severe COPD and intolerance to prolonged immobilization. The key discriminating factors are need for high local control, minimizing acute edema/long-term dysphagia, and shorter treatment time. For T2 glottic cancer with anterior commissure involvement, hyperfractionated radiotherapy (option C) is often recommended in guidelines (e.g., RTOG 9512) to improve local control while managing toxicity, and it fits the goal of balancing control and toxicity. Hypofractionation (B) is used for early glottic cancer but for T2 with anterior commissure extension, hyperfractionation is typically preferred. Option B is not the best-supported choice; C is more defensible. Main logical issue: key mismatch. Main medical accuracy: minor nuance—hypofractionation is acceptable for T1, but for T2 with anterior commissure, hyperfractionation is often favored. Minimal fix: Change key to C or adjust stem to specify T1 disease.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-014", "question": "A 60-year-old man with severe COPD (FEV1 30% predicted) undergoes right pneumonectomy for central squamous cell carcinoma. On postoperative day 3 he develops sudden respiratory distress, hypotension, and jugular venous distention. CXR shows mediastinal shift toward the left (remaining lung side) with hyperinflation and flattened diaphragm. Emergent bronchoscopy reveals no mucus plug. Echocardiogram shows right ventricular dilation and compression of the left atrium. Which is the most likely diagnosis?", "options": ["Postpneumonectomy pulmonary edema of the remaining lung", "Early bronchopleural fistula with tension pneumothorax on the pneumonectomy side", "Acute pulmonary embolism to the left pulmonary artery", "Postpneumonectomy syndrome due to mediastinal shift and bronchial kinking", "Cardiac tamponade from postoperative hemopericardium"], "answer": "D", "answer_index": 3, "explanation": "Postpneumonectomy syndrome is due to excessive mediastinal shift causing kinking/compression of the remaining main bronchus and cardiovascular structures; though classically delayed, it can present early with hyperinflation of the remaining lung and mediastinal shift toward it, leading to RV dilation and LA compression. Pulmonary edema (A) would not explain marked mediastinal shift. Tension pneumothorax on the pneumonectomy side (B) would shift mediastinum away from the remaining lung. Massive PE (C) lacks imaging features of overinflation and shift. Tamponade (E) shows equal chamber pressures but not lung overinflation or shift.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: sudden respiratory distress, hypotension, JVD post-pneumonectomy; CXR shows mediastinal shift toward remaining lung with hyperinflation; bronchoscopy negative for mucus plug; echo shows RV dilation and LA compression. The findings are classic for tension pneumothorax in the pneumonectomy space (option B), not postpneumonectomy syndrome (D). Postpneumonectomy syndrome typically presents later (weeks to years) with dyspnea and stridor due to bronchial compression, not acute cardiopulmonary collapse. The acute onset, mediastinal shift toward the remaining lung (indicating increased pressure on the pneumonectomy side), and hyperinflation of the remaining lung are pathognomonic for tension pneumothorax in the empty hemithorax, even without bronchopleural fistula explicitly stated. Option D is incorrect for acute presentation. Main logical issue: key mismatch. Main medical accuracy issue: misattribution of acute postoperative emergency to a typically delayed syndrome. Minimal fix: Change correct answer key to B and adjust rationale to explain tension pneumothorax in pneumonectomy space.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\": \n  \"3\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: sudden respiratory distress, hypotension, JVD post-pneumonectomy; CXR shows mediastinal shift toward remaining lung with hyperinflation; bronchoscopy negative for mucus plug; echo shows RV dilation and LA compression. The findings are classic for tension pneumothorax in the pneumonectomy space (option B), not postpneumonectomy syndrome (D). Postpneumonectomy syndrome typically presents later (weeks to years) with dyspnea and stridor due to bronchial compression, not acute cardiopulmonary collapse. The acute onset, mediastinal shift toward the remaining lung (indicating increased pressure on the pneumonectomy side), and hyperinflation of the remaining lung are pathognomonic for tension pneumothorax in the empty hemithorax, even without bronchopleural fistula explicitly stated. Option D is incorrect for acute presentation. Main logical issue: key mismatch. Main medical accuracy issue: misattribution of acute postoperative emergency to a typically delayed syndrome. Minimal fix: Change correct answer key to B and adjust rationale to explain tension pneumothorax in pneumonectomy space.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-015", "question": "A 67-year-old woman with lifestyle-limiting claudication and rest pain in the right foot has an occluded right common iliac artery and diffuse calcific disease of the ipsilateral external iliac and common femoral arteries. The left iliac system is patent with a prior kissing stent at the aortic bifurcation. Coronary disease and frailty preclude aortobifemoral bypass. Which revascularization option best optimizes long-term patency and limb salvage?", "options": ["Right axillo-femoral bypass using an 8-mm ringed PTFE graft to the common femoral artery", "Endovascular recanalization and stenting of the occluded right common iliac plus external iliac angioplasty", "Femoral-femoral crossover bypass from left common femoral artery to right profunda femoris artery with endarterectomy of the right common femoral", "Endovascular iliac recanalization combined with drug-coated balloon angioplasty of the common femoral artery", "Ilio-femoral bypass from left common iliac artery to right common femoral artery via a retroperitoneal route"], "answer": "C", "answer_index": 2, "explanation": "Given a hostile aorta and existing left iliac stent, fem-fem crossover with CFA endarterectomy to the profunda provides robust inflow and durable outflow while avoiding major aortic surgery. Axillo-femoral bypass (A) has lower long-term patency. Pure endovascular recanalization (B, D) may be limited by heavy CFA calcification and restenosis risk, and CFA is a poor stent target. Ilio-femoral bypass (E) is more invasive and may be technically challenging given the prior kissing stent and comorbidities.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: M (Multiple answers defensible). Verdict on keyed answer: Not uniquely determinable. Key stem clues: occluded right common iliac, diffuse calcific disease of external iliac and common femoral, left iliac patent with kissing stent, coronary disease/frailty preclude aortobifemoral bypass. The stem emphasizes optimizing long-term patency and limb salvage. Main logical issue: Options C and E are both reasonable and defensible. C (femoral-femoral crossover with endarterectomy) uses existing left inflow and addresses CFA disease, but E (ilio-femoral bypass) also uses left iliac inflow via retroperitoneal route, which can be durable and less invasive than aortic surgery. The stem does not provide details (e.g., severity of calcification, patient's surgical risk beyond 'frailty') to clearly favor one over the other. Both avoid the hostile aorta. Medical accuracy: The keyed answer (C) is a valid option, but E is also supported in guidelines for selected patients. The rationale dismisses E as 'more invasive and technically challenging,' but the stem's 'frailty' is vague, and retroperitoneal ilio-femoral bypass can be performed. Minimal fix: Specify that the right common femoral artery is heavily calcified and not suitable for anastomosis, making endarterectomy less ideal, thus favoring ilio-femoral bypass, or vice versa.\",\n  \"logical_false_reason\": \"M\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\": \n  \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict on keyed answer: Not uniquely determinable. Key stem clues: occluded right common iliac, diffuse calcific disease of external iliac and common femoral, left iliac patent with kissing stent, coronary disease/frailty preclude aortobifemoral bypass. The stem emphasizes optimizing long-term patency and limb salvage. Main logical issue: Options C and E are both reasonable and defensible. C (femoral-femoral crossover with endarterectomy) uses existing left inflow and addresses CFA disease, but E (ilio-femoral bypass) also uses left iliac inflow via retroperitoneal route, which can be durable and less invasive than aortic surgery. The stem does not provide details (e.g., severity of calcification, patient's surgical risk beyond 'frailty') to clearly favor one over the other. Both avoid the hostile aorta. Medical accuracy: The keyed answer (C) is a valid option, but E is also supported in guidelines for selected patients. The rationale dismisses E as 'more invasive and technically challenging,' but the stem's 'frailty' is vague, and retroperitoneal ilio-femoral bypass can be performed. Minimal fix: Specify that the right common femoral artery is heavily calcified and not suitable for anastomosis, making endarterectomy less ideal, thus favoring ilio-femoral bypass, or vice versa.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-016", "question": "A 58-year-old man with a 3.8-cm right thyroid nodule and compressive symptoms undergoes total thyroidectomy. Final pathology shows a 3.8-cm encapsulated follicular-patterned lesion with capsular and focal vascular invasion in 2 of 8 intracapsular vessels, RAS-mutant, no extrathyroidal extension, and no lymph node involvement. According to modern risk stratification and evolving nomenclature, which postoperative management is most appropriate?", "options": ["Classify as noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) and no further therapy", "Classify as minimally invasive follicular thyroid carcinoma and recommend routine radioactive iodine ablation", "Classify as encapsulated angioinvasive follicular variant papillary thyroid carcinoma and consider RAI only if postoperative thyroglobulin is detectable", "Classify as low-risk differentiated thyroid carcinoma managed with levothyroxine to keep TSH mildly suppressed and no routine RAI", "Classify as high-risk due to vascular invasion and treat with high-dose RAI and aggressive TSH suppression (<0.1 mIU/L)"], "answer": "D", "answer_index": 3, "explanation": "Encapsulated follicular-patterned tumors with limited vascular invasion (≤4 foci) and no extrathyroidal extension are considered low-risk differentiated thyroid carcinomas; current guidelines favor TSH suppression and no routine RAI, particularly in RAS-mutated lesions without nodal disease. NIFTP (A) requires no invasion; this lesion shows both capsular and vascular invasion. Routine RAI (B, E) is excessive for low-risk tumors. Labeling as high-risk (E) is not justified by limited angioinvasion alone. Option C misclassifies the entity and overemphasizes histologic subtype.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Endocrine", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: encapsulated follicular-patterned lesion, capsular and focal vascular invasion (2 of 8 vessels), RAS-mutant, no extrathyroidal extension, no lymph node involvement. These features align with modern risk stratification (e.g., ATA low-risk) for differentiated thyroid carcinoma. The item correctly identifies that limited vascular invasion (≤4 foci) without other high-risk features does not warrant routine radioactive iodine (RAI). Main logical issue: None; the stem provides sufficient detail to discriminate. Main medical accuracy issue: None; consistent with current guidelines (ATA 2015, updates). Minimal fix: None needed; item is clear and accurate.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\": \n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: encapsulated follicular-patterned lesion, capsular and focal vascular invasion (2 of 8 vessels), RAS-mutant, no extrathyroidal extension, no lymph node involvement. These features align with modern risk stratification (e.g., ATA low-risk) for differentiated thyroid carcinoma. The item correctly identifies that limited vascular invasion (≤4 foci) without other high-risk features does not warrant routine radioactive iodine (RAI). Main logical issue: None; the stem provides sufficient detail to discriminate. Main medical accuracy issue: None; consistent with current guidelines (ATA 2015, updates). Minimal fix: None needed; item is clear and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-017", "question": "A 66-year-old man with long-standing diabetes and peripheral neuropathy presents with chronic mesenteric ischemia symptoms and weight loss. CTA shows high-grade stenoses of both the celiac and superior mesenteric arteries (SMA) with a patent inferior mesenteric artery and extensive collateralization. There is a focal 2.5-cm jejunal stricture with mild upstream dilation but no mass. Intraoperatively, the bowel is patchy but viable; the stricture is firm and fibrotic. Biopsy shows transmural fibrosis without active vasculitis. Which strategy best addresses both symptoms and long-term gut viability?", "options": ["Endovascular stenting of SMA only, leaving celiac stenosis untreated", "Open antegrade aorto-SMA bypass plus segmental resection of the jejunal stricture", "Isolated resection of the jejunal stricture without mesenteric revascularization", "Retrograde iliac-to-SMA bypass only, with no bowel resection to avoid short-bowel risk", "Endovascular stenting of both celiac and SMA followed by observation of the stricture"], "answer": "B", "answer_index": 1, "explanation": "Symptomatic chronic mesenteric ischemia with structural fibrotic jejunal stricture requires both durable inflow restoration and removal of the fixed lesion; open aorto-SMA bypass offers superior long-term patency in multivessel disease, and resection treats the fibrotic stricture. SMA-only stenting (A) or dual-vessel stenting (E) may have higher restenosis and do not resolve fixed fibrosis. Resection alone (C) ignores global ischemia. Retrograde iliac-SMA bypass without resection (D) leaves a mechanical obstruction.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: chronic mesenteric ischemia with multivessel stenoses (celiac and SMA), patent IMA with collaterals, and a focal fibrotic jejunal stricture with viable but patchy bowel. The combination of chronic ischemia and a fixed fibrotic stricture necessitates both revascularization and resection. Main logical issue: None; the stem provides sufficient detail to uniquely support option B. Main medical accuracy issue: None; the reasoning aligns with vascular surgery principles: durable open bypass (aorto-SMA) for multivessel disease and resection of a fibrotic stricture is standard. Minimal fix: None required; the item is clear and accurate.\", \"logical_false_reason\": \"T\", \"logical_validity\": true, \"medical_accuracy_score\":  \"5\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: chronic mesenteric ischemia with multivessel stenoses (celiac and SMA), patent IMA with collaterals, and a focal fibrotic jejunal stricture with viable but patchy bowel. The combination of chronic ischemia and a fixed fibrotic stricture necessitates both revascularization and resection. Main logical issue: None; the stem provides sufficient detail to uniquely support option B. Main medical accuracy issue: None; the reasoning aligns with vascular surgery principles: durable open bypass (aorto-SMA) for multivessel disease and resection of a fibrotic stricture is standard. Minimal fix: None required; the item is clear and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-018", "question": "A 52-year-old woman with a history of Roux-en-Y gastric bypass 8 years ago presents with refractory iron-deficiency anemia and vague postprandial epigastric pain. EGD and colonoscopy are negative. Capsule endoscopy shows a circumferential, friable lesion in the excluded stomach. CT enterography confirms a 3.5-cm mass in the excluded gastric remnant without metastatic disease. Which surgical approach is most appropriate for oncologic control and access limitations?", "options": ["Laparoscopic transgastric gastroscopy through the gastric pouch with submucosal dissection of the lesion", "Laparoscopic-assisted resection of the excluded stomach mass via gastrotomy in the remnant and wedge resection", "Conversion of the Roux-en-Y gastric bypass to normal anatomy followed by subtotal gastrectomy", "Open completion gastrectomy including the excluded stomach with Roux-en-Y esophagojejunostomy", "Endoscopic ultrasound-guided radiofrequency ablation of the mass via transluminal puncture from the alimentary limb"], "answer": "D", "answer_index": 3, "explanation": "A 3.5-cm circumferential, friable mass in the excluded stomach is highly suspicious for carcinoma; completion gastrectomy provides oncologic resection with appropriate lymphadenectomy, best achieved via open approach given altered anatomy and access. Laparoscopic wedge resection (B) is inadequate for circumferential malignancy. Converting anatomy first (C) adds complexity without oncologic benefit. Transgastric endoscopic resection (A) and RFA (E) are inappropriate for likely invasive carcinoma in an excluded segment.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: Refractory iron-deficiency anemia, vague postprandial pain, negative EGD/colonoscopy, capsule endoscopy shows circumferential friable lesion in excluded stomach, CT shows 3.5-cm mass without metastasis. The clinical scenario strongly suggests gastric carcinoma in the excluded remnant after Roux-en-Y gastric bypass. The question asks for the most appropriate surgical approach for oncologic control given access limitations. The keyed answer (D, open completion gastrectomy with Roux-en-Y esophagojejunostomy) is the standard oncologic resection for a likely gastric cancer in this setting, providing adequate lymphadenectomy and margin control. Alternatives are inadequate: A and E are endoscopic/local therapies inappropriate for a large, likely invasive carcinoma; B (wedge resection) is insufficient for a circumferential lesion; C (conversion then gastrectomy) adds unnecessary steps. No internal contradictions or missing critical details. Medical accuracy is sound, aligning with surgical oncology principles for gastric remnant cancer. Minimal fix: None required for validity; to enhance clarity, could specify 'suspected adenocarcinoma' in the stem.\", \"logical_false_reason\": \"T\", \"logical_validity\": true, \"medical_accuracy_score\":  \"4\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: Refractory iron-deficiency anemia, vague postprandial pain, negative EGD/colonoscopy, capsule endoscopy shows circumferential friable lesion in excluded stomach, CT shows 3.5-cm mass without metastasis. The clinical scenario strongly suggests gastric carcinoma in the excluded remnant after Roux-en-Y gastric bypass. The question asks for the most appropriate surgical approach for oncologic control given access limitations. The keyed answer (D, open completion gastrectomy with Roux-en-Y esophagojejunostomy) is the standard oncologic resection for a likely gastric cancer in this setting, providing adequate lymphadenectomy and margin control. Alternatives are inadequate: A and E are endoscopic/local therapies inappropriate for a large, likely invasive carcinoma; B (wedge resection) is insufficient for a circumferential lesion; C (conversion then gastrectomy) adds unnecessary steps. No internal contradictions or missing critical details. Medical accuracy is sound, aligning with surgical oncology principles for gastric remnant cancer. Minimal fix: None required for validity; to enhance clarity, could specify 'suspected adenocarcinoma' in the stem.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-019", "question": "A 45-year-old man with newly diagnosed mantle cell lymphoma receives R-CHOP followed by high-dose cytarabine. Six months later, he presents with worsening fatigue. CBC shows Hb 7.5 g/dL, MCV 105 fL, WBC 2,000/µL, platelets 40,000/µL. Bone marrow biopsy shows 18% myeloblasts with multilineage dysplasia and complex cytogenetics including monosomy 7. Flow cytometry is consistent with therapy-related myelodysplastic syndrome evolving toward AML. He has an HCT-CI score of 4 and a matched unrelated donor. Which management approach offers the best chance of long-term survival?", "options": ["Continue R-CHOP for mantle cell lymphoma and start azacitidine for t-MDS", "High-intensity induction chemotherapy with 7+3 followed by allogeneic stem cell transplantation in first remission", "Azacitidine plus venetoclax for cytoreduction, then allogeneic stem cell transplantation when feasible", "Supportive care only with transfusions and growth factors due to high transplant risk", "Immediate reduced-intensity allogeneic transplantation without further cytoreduction"], "answer": "C", "answer_index": 2, "explanation": "Therapy-related MDS/AML with complex karyotype has poor prognosis; hypomethylating agent plus venetoclax can achieve remissions with better tolerability than intensive 7+3 in a comorbid patient, allowing subsequent allogeneic transplant for potential cure. Continuing lymphoma chemo (A) ignores aggressive secondary myeloid disease. High-intensity induction (B) risks excess toxicity given HCT-CI 4. Supportive care alone (D) is palliative. Immediate RIC transplant without cytoreduction (E) in 18% blasts is associated with high relapse and graft failure rates.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Hematology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: 45-year-old with therapy-related MDS/AML (18% blasts, complex cytogenetics including monosomy 7) after lymphoma therapy, HCT-CI score of 4, matched unrelated donor available. The stem specifies 'best chance of long-term survival.' Main logical issue: The keyed answer (C: azacitidine+venetoclax, then transplant) is not the single best answer. For fit patients with therapy-related AML (even with HCT-CI 4, which is intermediate risk) and a matched donor, current guidelines (NCCN, ELN) recommend proceeding to allogeneic transplant as the only curative option. The most direct and evidence-based path to long-term survival is induction to achieve remission followed by transplant. Option B (high-intensity induction followed by transplant in first remission) is the standard of care for eligible patients, including many with therapy-related AML, and is defensible as best. Option C represents an alternative lower-intensity induction, but is not definitively superior for long-term survival in this scenario, creating ambiguity. Main medical accuracy issue: The key implies azacitidine+venetoclax is superior to intensive induction for a patient with an HCT-CI of 4, but HCT-CI 4 does not automatically preclude intensive induction; fitness and organ function are more critical, and the stem does not specify contraindications to intensive chemo. Minimal fix: Change the key to B and adjust the rationale to reflect that for a relatively young (45-year-old) patient with a matched donor, intensive induction aiming for remission followed by allogeneic transplant offers the best chance of cure, acknowledging that lower-intensity regimens are alternatives for unfit patients.\", \"logical_false_reason\": \"K\", \"logical_validity\": false, \"medical_accuracy_score\": \t\"4\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: 45-year-old with therapy-related MDS/AML (18% blasts, complex cytogenetics including monosomy 7) after lymphoma therapy, HCT-CI score of 4, matched unrelated donor available. The stem specifies 'best chance of long-term survival.' Main logical issue: The keyed answer (C: azacitidine+venetoclax, then transplant) is not the single best answer. For fit patients with therapy-related AML (even with HCT-CI 4, which is intermediate risk) and a matched donor, current guidelines (NCCN, ELN) recommend proceeding to allogeneic transplant as the only curative option. The most direct and evidence-based path to long-term survival is induction to achieve remission followed by transplant. Option B (high-intensity induction followed by transplant in first remission) is the standard of care for eligible patients, including many with therapy-related AML, and is defensible as best. Option C represents an alternative lower-intensity induction, but is not definitively superior for long-term survival in this scenario, creating ambiguity. Main medical accuracy issue: The key implies azacitidine+venetoclax is superior to intensive induction for a patient with an HCT-CI of 4, but HCT-CI 4 does not automatically preclude intensive induction; fitness and organ function are more critical, and the stem does not specify contraindications to intensive chemo. Minimal fix: Change the key to B and adjust the rationale to reflect that for a relatively young (45-year-old) patient with a matched donor, intensive induction aiming for remission followed by allogeneic transplant offers the best chance of cure, acknowledging that lower-intensity regimens are alternatives for unfit patients.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-020", "question": "A 32-year-old man with long-standing severe atopic dermatitis refractory to topical steroids and cyclosporine is started on dupilumab (anti-IL-4Rα). After 5 months, his skin disease improves markedly, but he develops new-onset peripheral eosinophilia (AEC 3,000/µL), adult-onset asthma, and transient pulmonary infiltrates on CT. ANCA is negative, and biopsy of a skin nodule shows eosinophil-rich vasculitis of small vessels. Which immunologic mechanism best explains this paradoxical adverse event?", "options": ["Unopposed IL-5-mediated eosinophil proliferation due to blockade of IL-4/IL-13 signaling", "Expansion of Th17 cells with increased IL-17 production driven by IL-4 pathway inhibition", "Emergence of autoreactive B cells secondary to impaired regulatory T-cell differentiation", "Type I interferon upregulation resulting from altered JAK-STAT signaling downstream of IL-4Rα", "Loss of IL-31 signaling leading to compensatory mast cell activation and eosinophilia"], "answer": "A", "answer_index": 0, "explanation": "Dupilumab blocks IL-4/IL-13 signaling, which can shift the Th2 cytokine milieu and lead to relative dominance of IL-5-driven eosinophil proliferation and activation, precipitating eosinophilic vasculitis/EGPA-like syndromes in susceptible patients. Th17 expansion (B), autoreactive B cells via Treg failure (C), interferon upregulation (D), or IL-31/mast cell effects (E) do not directly account for marked eosinophilia and small-vessel eosinophilic vasculitis associated with IL-4Rα blockade.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: dupilumab (anti-IL-4Rα) therapy, subsequent development of peripheral eosinophilia, asthma, pulmonary infiltrates, and eosinophil-rich small-vessel vasculitis with negative ANCA. This pattern suggests an eosinophilic syndrome (e.g., EGPA-like) driven by IL-5 due to IL-4/IL-13 pathway blockade. Main logical issue: None; the vignette uniquely supports option A. Main medical accuracy issue: The described paradoxical adverse event is a recognized, though rare, phenomenon with dupilumab, aligning with current literature on IL-4/IL-13 inhibition potentially unmasking IL-5-driven eosinophilia. Minimal fix: None required for validity; to enhance clarity, the stem could explicitly note the absence of other causes (e.g., parasitic infection) to further solidify the link to dupilumab.\",\n  \"medical_accuracy_score\":  \"4\",\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: dupilumab (anti-IL-4Rα) therapy, subsequent development of peripheral eosinophilia, asthma, pulmonary infiltrates, and eosinophil-rich small-vessel vasculitis with negative ANCA. This pattern suggests an eosinophilic syndrome (e.g., EGPA-like) driven by IL-5 due to IL-4/IL-13 pathway blockade. Main logical issue: None; the vignette uniquely supports option A. Main medical accuracy issue: The described paradoxical adverse event is a recognized, though rare, phenomenon with dupilumab, aligning with current literature on IL-4/IL-13 inhibition potentially unmasking IL-5-driven eosinophilia. Minimal fix: None required for validity; to enhance clarity, the stem could explicitly note the absence of other causes (e.g., parasitic infection) to further solidify the link to dupilumab.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}]